NARA Discovery
Article Details
← Back to Search Results
Journal Article

Measuring and addressing health equity: an assessment of cancer center designation requirements

Jason T. Semprini; Caitlin B. Biddell; Jan M. Eberth; Mary E. Charlton; Sarah H. Nash; Katherine A. Yeager; Donoria Evans; Purnima Madhivanan; Heather M. Brandt; Natoshia M. Askelson; Aaron T. Seaman; Whitney E. Zahnd
Cancer Causes & Control · Vol. 34, Issue S1 · pp. 23-33 · 2023

Abstract

Purpose By requiring specific measures, cancer endorsements (e.g., accreditations, designations, certifications) promote high-quality cancer care. While 'quality' is the defining feature, less is known about how these endorsements consider equity. Given the inequities in access to high-quality cancer care, we assessed the extent to which equity structures, processes, and outcomes were required for cancer center endorsements. Methods We performed a content analysis of medical oncology, radiation oncology, surgical oncology, and research hospital endorsements from the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO), American College of Surgeons Commission on Cancer (CoC), and the National Cancer Institute (NCI), respectively. We analyzed requirements for equity-focused content and compared how each endorsing body included equity as a requirement along three axes: structures, processes, and outcomes. Results ASCO guidelines centered on processes assessing financial, health literacy, and psychosocial barriers to care. ASTRO guidelines related to language needs and processes to address financial barriers. CoC equity-related guidelines focused on processes addressing financial and psychosocial concerns of survivors, and hospital-identified barriers to care. NCI guidelines considered equity related to cancer disparities research, inclusion of diverse groups in outreach and clinical trials, and diversification of investigators. None of the guidelines explicitly required measures of equitable care delivery or outcomes beyond clinical trial enrollment. Conclusion Overall, equity requirements were limited. Leveraging the influence and infrastructure of cancer quality endorsements could enhance progress toward achieving cancer care equity. We recommend that endorsing organizations 1) require cancer centers to implement processes for measuring and tracking health equity outcomes and 2) engage diverse community stakeholders to develop strategies for addressing discrimination.

Bibliographic Information

JournalCancer Causes & Control
PublisherSpringer
Publication Date2023-12-01
Publication Year2023
Volume34
IssueS1
Pages23-33
Document TypeJournal Article
Print ISSN0957-5243
eISSN1573-7225
DOI10.1007/s10552-023-01680-4

Access Information

NARA Access Coverage1990-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10552
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.